TY - JOUR AU - Neogi, T. PY - 2011 DA - 2011// TI - Clinical practice: gout JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMcp1001124 DO - 10.1056/NEJMcp1001124 ID - Neogi2011 ER - TY - JOUR AU - Kuo, C. F. AU - Grainge, M. J. AU - Mallen, C. AU - Zhang, W. AU - Doherty, M. PY - 2015 DA - 2015// TI - Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204463 DO - 10.1136/annrheumdis-2013-204463 ID - Kuo2015 ER - TY - JOUR AU - Lawrence, R. C. AU - Felson, D. T. AU - Helmick, C. G. AU - Arnold, L. M. AU - Choi, H. AU - Deyo, R. A. AU - Gabriel, S. AU - Hirsch, R. AU - Hochberg, M. C. AU - Hunder, G. G. PY - 2008 DA - 2008// TI - Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23176 DO - 10.1002/art.23176 ID - Lawrence2008 ER - TY - JOUR AU - Wallace, K. L. AU - Riedel, A. A. AU - Joseph-Ridge, N. AU - Wortmann, R. PY - 2004 DA - 2004// TI - Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population JO - J Rheumatol VL - 31 ID - Wallace2004 ER - TY - JOUR AU - Zhu, Y. AU - Pandya, B. J. AU - Choi, H. K. PY - 2011 DA - 2011// TI - Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008 JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30520 DO - 10.1002/art.30520 ID - Zhu2011 ER - TY - JOUR AU - Kuo, C. F. AU - Grainge, M. J. AU - Zhang, W. AU - Doherty, M. PY - 2015 DA - 2015// TI - Global epidemiology of gout: prevalence, incidence and risk factors JO - Nat Rev Rheumatol VL - 11 UR - https://doi.org/10.1038/nrrheum.2015.91 DO - 10.1038/nrrheum.2015.91 ID - Kuo2015 ER - TY - JOUR AU - Shields, G. E. AU - Beard, S. M. PY - 2015 DA - 2015// TI - A systematic review of the economic and humanistic burden of gout JO - Pharmacoeconomics VL - 33 UR - https://doi.org/10.1007/s40273-015-0288-5 DO - 10.1007/s40273-015-0288-5 ID - Shields2015 ER - TY - JOUR AU - Jordan, K. M. AU - Cameron, J. S. AU - Snaith, M. AU - Zhang, W. AU - Doherty, M. AU - Seckl, J. AU - Hingorani, A. AU - Jaques, R. AU - Nuki, G. PY - 2007 DA - 2007// TI - British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout JO - Rheumatology (Oxford) VL - 46 UR - https://doi.org/10.1093/rheumatology/kem056a DO - 10.1093/rheumatology/kem056a ID - Jordan2007 ER - TY - JOUR AU - Khanna, D. AU - Khanna, P. P. AU - Fitzgerald, J. D. AU - Singh, M. K. AU - Bae, S. AU - Neogi, T. AU - Pillinger, M. H. AU - Merill, J. AU - Lee, S. AU - Prakash, S. PY - 2012 DA - 2012// TI - 2012 American College of Rheumatology guidelines for management of gout, part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis JO - Arthritis Care Res VL - 64 UR - https://doi.org/10.1002/acr.21773 DO - 10.1002/acr.21773 ID - Khanna2012 ER - TY - JOUR AU - Khanna, P. AU - Hagerty, D. AU - Mischler, R. AU - Morlock, R. PY - 2012 DA - 2012// TI - Adherence to EULAR recommendations for the treatment of gout [EULAR abstract FRI0397] JO - Ann Rheum Dis VL - 71 suppl 3 ID - Khanna2012 ER - TY - JOUR AU - Zhang, W. AU - Doherty, M. AU - Bardin, T. AU - Pascual, E. AU - Barskova, V. AU - Conaghan, P. AU - Gerster, J. AU - Jacobs, J. AU - Leeb, B. AU - Liote, F. PY - 2006 DA - 2006// TI - EULAR evidence based recommendations for gout, part II: management: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2006.055269 DO - 10.1136/ard.2006.055269 ID - Zhang2006 ER - TY - JOUR AU - Zhang, W. AU - Doherty, M. AU - Pascual, E. AU - Bardin, T. AU - Barskova, V. AU - Conaghan, P. AU - Gerster, J. AU - Jacobs, J. AU - Leeb, B. AU - Liote, F. PY - 2006 DA - 2006// TI - EULAR evidence based recommendations for gout, part I: diagnosis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2006.055251 DO - 10.1136/ard.2006.055251 ID - Zhang2006 ER - TY - JOUR AU - Liu, S. AU - Perez-Ruiz, F. AU - Miner, J. N. PY - 2016 DA - 2016// TI - Patients with gout differ from healthy subjects in renal response to changes in serum uric acid JO - Joint Bone Spine VL - S1297–319X ID - Liu2016 ER - TY - JOUR AU - Terkeltaub, R. PY - 2010 DA - 2010// TI - Update on gout: new therapeutic strategies and options JO - Nat Rev Rheumatol VL - 6 UR - https://doi.org/10.1038/nrrheum.2009.236 DO - 10.1038/nrrheum.2009.236 ID - Terkeltaub2010 ER - TY - JOUR AU - Choi, H. K. AU - Mount, D. B. AU - Reginato, A. M. PY - 2005 DA - 2005// TI - Pathogenesis of gout JO - Ann Intern Med VL - 143 UR - https://doi.org/10.7326/0003-4819-143-7-200510040-00009 DO - 10.7326/0003-4819-143-7-200510040-00009 ID - Choi2005 ER - TY - JOUR AU - Dehghan, A. AU - Köttgen, A. AU - Yang, Q. AU - Hwang, S. J. AU - Kao, W. L. AU - Rivadeneira, F. AU - Boerwinkle, E. AU - Levy, D. AU - Hofman, A. AU - Astor, B. C. PY - 2008 DA - 2008// TI - Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61343-4 DO - 10.1016/S0140-6736(08)61343-4 ID - Dehghan2008 ER - TY - JOUR AU - Kolz, M. AU - Johnson, T. AU - Sanna, S. AU - Teumer, A. AU - Vitart, V. AU - Perola, M. AU - Mangino, M. AU - Albrecht, E. AU - Wallace, C. AU - Farrall, M. PY - 2009 DA - 2009// TI - Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations JO - PLoS Genet VL - 5 UR - https://doi.org/10.1371/journal.pgen.1000504 DO - 10.1371/journal.pgen.1000504 ID - Kolz2009 ER - TY - JOUR AU - Kottgen, A. AU - Albrecht, E. AU - Teumer, A. AU - Vitart, V. AU - Krumsiek, J. AU - Hundertmark, C. AU - Pistis, G. AU - Ruggiero, D. AU - O'Seaghdha, C. M. AU - Haller, T. PY - 2013 DA - 2013// TI - Genome-wide association analyses identify 18 new loci associated with serum urate concentrations JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2500 DO - 10.1038/ng.2500 ID - Kottgen2013 ER - TY - JOUR AU - Enomoto, A. AU - Kimura, H. AU - Chairoungdua, A. AU - Shigeta, Y. AU - Jutabha, P. AU - Cha, S. H. AU - Hosoyamada, M. AU - Takeda, M. AU - Sekine, T. AU - Igarashi, T. PY - 2002 DA - 2002// TI - Molecular identification of a renal urate anion exchanger that regulates blood urate levels JO - Nature VL - 417 ID - Enomoto2002 ER - TY - JOUR AU - Ichida, K. AU - Hosoyamada, M. AU - Hisatome, I. AU - Enomoto, A. AU - Hikita, M. AU - Endou, H. AU - Hosoya, T. PY - 2004 DA - 2004// TI - Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion JO - J Am Soc Nephrol VL - 15 UR - https://doi.org/10.1097/01.ASN.0000105320.04395.D0 DO - 10.1097/01.ASN.0000105320.04395.D0 ID - Ichida2004 ER - TY - JOUR AU - Anzai, N. AU - Ichida, K. AU - Jutabha, P. AU - Kimura, T. AU - Babu, E. AU - Jin, C. J. AU - Srivastava, S. AU - Kitamura, K. AU - Hisatome, I. AU - Endou, H. PY - 2008 DA - 2008// TI - Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.C800156200 DO - 10.1074/jbc.C800156200 ID - Anzai2008 ER - TY - JOUR AU - Matsuo, H. AU - Chiba, T. AU - Nagamori, S. AU - Nakayama, A. AU - Domoto, H. AU - Phetdee, K. AU - Wiriyasermkul, P. AU - Kikuchi, Y. AU - Oda, T. AU - Nishiyama, J. PY - 2008 DA - 2008// TI - Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia JO - Am J Hum Genet VL - 83 UR - https://doi.org/10.1016/j.ajhg.2008.11.001 DO - 10.1016/j.ajhg.2008.11.001 ID - Matsuo2008 ER - TY - JOUR AU - Vitart, V. AU - Rudan, I. AU - Hayward, C. AU - Gray, N. K. AU - Floyd, J. AU - Palmer, C. N. AU - Knott, S. A. AU - Kolcic, I. AU - Polasek, O. AU - Graessler, J. PY - 2008 DA - 2008// TI - SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout JO - Nat Genet VL - 40 UR - https://doi.org/10.1038/ng.106 DO - 10.1038/ng.106 ID - Vitart2008 ER - TY - JOUR AU - Flynn, T. J. AU - Phipps-Green, A. AU - Hollis-Moffatt, J. E. AU - Merriman, M. E. AU - Topless, R. AU - Montgomery, G. AU - Chapman, B. AU - Stamp, L. K. AU - Dalbeth, N. AU - Merriman, T. R. PY - 2013 DA - 2013// TI - Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects JO - Arthritis Res Ther VL - 15 UR - https://doi.org/10.1186/ar4417 DO - 10.1186/ar4417 ID - Flynn2013 ER - TY - JOUR AU - Reyes, A. J. PY - 2003 DA - 2003// TI - Cardiovascular drugs and serum uric acid JO - Cardiovasc Drugs Ther VL - 17 UR - https://doi.org/10.1023/B:CARD.0000015855.02485.e3 DO - 10.1023/B:CARD.0000015855.02485.e3 ID - Reyes2003 ER - TY - JOUR AU - Hagos, Y. AU - Bahn, A. AU - Vormfelde, S. V. AU - Brockmoller, J. AU - Burckhardt, G. PY - 2007 DA - 2007// TI - Torasemide transport by organic anion transporters contributes to hyperuricemia JO - J Am Soc Nephrol VL - 18 UR - https://doi.org/10.1681/ASN.2007010106 DO - 10.1681/ASN.2007010106 ID - Hagos2007 ER - TY - JOUR AU - Hagos, Y. AU - Stein, D. AU - Ugele, B. AU - Burckhardt, G. AU - Bahn, A. PY - 2007 DA - 2007// TI - Human renal organic anion transporter 4 operates as an asymmetric urate transporter JO - J Am Soc Nephrol VL - 18 UR - https://doi.org/10.1681/ASN.2006040415 DO - 10.1681/ASN.2006040415 ID - Hagos2007 ER - TY - JOUR AU - McAdams-DeMarco, M. A. AU - Maynard, J. W. AU - Baer, A. N. AU - Kao, L. W. AU - Kottgen, A. AU - Coresh, J. PY - 2013 DA - 2013// TI - A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2011-201186 DO - 10.1136/annrheumdis-2011-201186 ID - McAdams-DeMarco2013 ER - TY - JOUR AU - Cunningham, R. F. AU - Israili, Z. H. AU - Dayton, P. G. PY - 1981 DA - 1981// TI - Clinical pharmacokinetics of probenecid JO - Clin Pharmacokinet VL - 6 UR - https://doi.org/10.2165/00003088-198106020-00004 DO - 10.2165/00003088-198106020-00004 ID - Cunningham1981 ER - TY - JOUR AU - Burckhardt, G. PY - 2012 DA - 2012// TI - Drug transport by organic anion transporters (OATs) JO - Pharmacol Ther VL - 136 UR - https://doi.org/10.1016/j.pharmthera.2012.07.010 DO - 10.1016/j.pharmthera.2012.07.010 ID - Burckhardt2012 ER - TY - JOUR AU - Lee, M. -. H. H. AU - Graham, G. G. AU - Williams, K. M. AU - Day, R. O. PY - 2008 DA - 2008// TI - A benefit-risk assessment of benzbromarone in the treatment of gout: was its withdrawal from the market in the best interest of patients? JO - Drug Saf VL - 31 UR - https://doi.org/10.2165/00002018-200831080-00002 DO - 10.2165/00002018-200831080-00002 ID - Lee2008 ER - TY - JOUR AU - Derosa, G. AU - Maffioli, P. AU - Sahebkar, A. PY - 2015 DA - 2015// TI - Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials JO - Pharmacol Res VL - 102 UR - https://doi.org/10.1016/j.phrs.2015.09.012 DO - 10.1016/j.phrs.2015.09.012 ID - Derosa2015 ER - TY - JOUR AU - Wolff, M. L. AU - Cruz, J. L. AU - Vanderman, A. J. AU - Brown, J. N. PY - 2015 DA - 2015// TI - The effect of angiotensin II receptor blockers on hyperuricemia JO - Ther Adv Chronic Dis VL - 6 UR - https://doi.org/10.1177/2040622315596119 DO - 10.1177/2040622315596119 ID - Wolff2015 ER - TY - JOUR AU - Fleischmann, R. AU - Kerr, B. AU - Yeh, L. T. AU - Suster, M. AU - Shen, Z. AU - Polvent, E. AU - Hingorani, V. AU - Quart, B. AU - Manhard, K. AU - Miner, J. N. PY - 2014 DA - 2014// TI - Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia JO - Rheumatology (Oxford) VL - 53 UR - https://doi.org/10.1093/rheumatology/ket487 DO - 10.1093/rheumatology/ket487 ID - Fleischmann2014 ER - TY - JOUR AU - Shen, Z. AU - Rowlings, C. AU - Kerr, B. AU - Hingorani, V. AU - Manhard, K. AU - Quart, B. AU - Yeh, L. T. AU - Storgard, C. PY - 2015 DA - 2015// TI - Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males JO - Drug Des Dev Ther VL - 9 UR - https://doi.org/10.2147/DDDT.S85193 DO - 10.2147/DDDT.S85193 ID - Shen2015 ER - TY - JOUR AU - Mount, D. B. PY - 2013 DA - 2013// TI - The kidney in hyperuricemia and gout JO - Curr Opin Nephrol Hypertens VL - 22 UR - https://doi.org/10.1097/MNH.0b013e32835ddad2 DO - 10.1097/MNH.0b013e32835ddad2 ID - Mount2013 ER - TY - JOUR AU - Perez-Ruiz, F. AU - Sundy, J. S. AU - Miner, J. N. AU - Cravets, M. AU - Storgard, C. AU - Group, R. S. PY - 2016 DA - 2016// TI - Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207919 DO - 10.1136/annrheumdis-2015-207919 ID - Perez-Ruiz2016 ER - TY - JOUR AU - Hoy, S. M. PY - 2016 DA - 2016// TI - Lesinurad. First Global Approval JO - Drugs VL - 76 UR - https://doi.org/10.1007/s40265-016-0550-y DO - 10.1007/s40265-016-0550-y ID - Hoy2016 ER - TY - JOUR AU - Fenner, K. S. AU - Troutman, M. D. AU - Kempshall, S. AU - Cook, J. A. AU - Ware, J. A. AU - Smith, D. A. AU - Lee, C. A. PY - 2009 DA - 2009// TI - Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug JO - Clin Pharmacol Ther VL - 85 UR - https://doi.org/10.1038/clpt.2008.195 DO - 10.1038/clpt.2008.195 ID - Fenner2009 ER - TY - JOUR AU - Woodward, O. M. AU - Kottgen, A. AU - Kottgen, M. PY - 2011 DA - 2011// TI - ABCG transporters and disease JO - FEBS J VL - 278 UR - https://doi.org/10.1111/j.1742-4658.2011.08171.x DO - 10.1111/j.1742-4658.2011.08171.x ID - Woodward2011 ER - TY - JOUR AU - Shen, Z. AU - Yeh, L. T. AU - Wallach, K. AU - Zhu, N. AU - Kerr, B. AU - Gillen, M. PY - 2016 DA - 2016// TI - In vitro and in vivo interaction studies between lesinurad, a selective urate reabsorption inhibitor, and major liver or kidney transporters JO - Clin Drug Investig VL - 36 UR - https://doi.org/10.1007/s40261-016-0386-y DO - 10.1007/s40261-016-0386-y ID - Shen2016 ER - TY - JOUR AU - Kaufmann, P. AU - Torok, M. AU - Hanni, A. AU - Roberts, P. AU - Gasser, R. AU - Krahenbuhl, S. PY - 2005 DA - 2005// TI - Mechanisms of benzarone and benzbromarone-induced hepatic toxicity JO - Hepatology VL - 41 UR - https://doi.org/10.1002/hep.20634 DO - 10.1002/hep.20634 ID - Kaufmann2005 ER - TY - JOUR AU - Broekhuysen, J. AU - Pacco, M. AU - Sion, R. AU - Demeulenaere, L. AU - Hee, M. PY - 1972 DA - 1972// TI - Metabolism of benzbromarone in man JO - Eur J Clin Pharmacol VL - 4 UR - https://doi.org/10.1007/BF00562509 DO - 10.1007/BF00562509 ID - Broekhuysen1972 ER - TY - JOUR AU - Karalliedde, J. AU - Buckingham, R. E. PY - 2007 DA - 2007// TI - Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies JO - Drug Saf VL - 30 UR - https://doi.org/10.2165/00002018-200730090-00002 DO - 10.2165/00002018-200730090-00002 ID - Karalliedde2007 ER - TY - JOUR AU - Kunishima, C. AU - Inoue, I. AU - Oikawa, T. AU - Nakajima, H. AU - Komoda, T. AU - Katayama, S. PY - 2007 DA - 2007// TI - Activating effect of benzbromarone, a uricosuric drug, on peroxisome proliferator-activated receptors JO - PPAR Res VL - 2007 UR - https://doi.org/10.1155/2007/36092 DO - 10.1155/2007/36092 ID - Kunishima2007 ER - TY - STD TI - Bardin T, Keenan R, Khanna P, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, So A. Lesinurad, a selective uric acid reabsorption inhibitor, in combination with allopurinol: results from a phase III study in gout patients having an inadequate response to standard of care (CLEAR 2). Poster presented at 16th EULAR Annual European Congress of Rheumatology, Rome, Italy, June 10-13, 2015; Poster FRI0333. ID - ref46 ER - TY - STD TI - Saag KG, Fitz-Patrick D, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, Becker M. Lesinurad, a selective uric acid reabsorption inhibitor, in combination with allopurinol: results from a phase III study in gout patients having an inadequate response to standard of care (CLEAR 1). Poster presented at 16th EULAR Annual European Congress of Rheumatology, Rome, Italy, June 10-13, 2015; Poster FRI0320. ID - ref47 ER - TY - JOUR AU - Heel, R. C. AU - Brogden, R. N. AU - Speight, T. M. AU - Avery, G. S. PY - 1977 DA - 1977// TI - Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia JO - Drugs VL - 14 UR - https://doi.org/10.2165/00003495-197714050-00002 DO - 10.2165/00003495-197714050-00002 ID - Heel1977 ER - TY - JOUR AU - Iwanaga, T. AU - Kobayashi, D. AU - Hirayama, M. AU - Maeda, T. AU - Tamai, I. PY - 2005 DA - 2005// TI - Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone JO - Drug Metab Dispos VL - 33 ID - Iwanaga2005 ER - TY - STD TI - U.S. Department of Health and Human Services. Guidance for Industry. Drug Interaction Studies-—Study Design, Data Analysis, Implications for Dosing and Labeling Recommendations. US Food and Drug Administration. February 2012. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf. UR - http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf ID - ref50 ER - TY - JOUR AU - Honari, J. AU - Blair, A. D. AU - Cutler, R. E. PY - 1977 DA - 1977// TI - Effects of probenecid on furosemide kinetics and natriuresis in man JO - Clin Pharmacol Ther VL - 22 UR - https://doi.org/10.1002/cpt1977224395 DO - 10.1002/cpt1977224395 ID - Honari1977 ER - TY - JOUR AU - Vallon, V. AU - Rieg, T. AU - Ahn, S. Y. AU - Wu, W. AU - Eraly, S. A. AU - Nigam, S. K. PY - 2008 DA - 2008// TI - Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics JO - Am J Physiol Renal Physiol VL - 294 UR - https://doi.org/10.1152/ajprenal.00528.2007 DO - 10.1152/ajprenal.00528.2007 ID - Vallon2008 ER - TY - JOUR AU - Lepist, E. I. AU - Ray, A. S. PY - 2012 DA - 2012// TI - Renal drug-drug interactions: what we have learned and where we are going JO - Expert Opin Drug Metab Toxicol VL - 8 UR - https://doi.org/10.1517/17425255.2012.667401 DO - 10.1517/17425255.2012.667401 ID - Lepist2012 ER - TY - JOUR AU - Nigam, S. K. AU - Wu, W. AU - Bush, K. T. AU - Hoenig, M. P. AU - Blantz, R. C. AU - Bhatnagar, V. PY - 2015 DA - 2015// TI - Handling of Drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters JO - Clin J Am Soc Nephrol VL - 10 UR - https://doi.org/10.2215/CJN.02440314 DO - 10.2215/CJN.02440314 ID - Nigam2015 ER - TY - JOUR AU - Caulfield, M. J. AU - Munroe, P. B. AU - O'Neill, D. AU - Witkowska, K. AU - Charchar, F. J. AU - Doblado, M. AU - Evans, S. AU - Eyheramendy, S. AU - Onipinla, A. AU - Howard, P. PY - 2008 DA - 2008// TI - SLC2A9 is a high-capacity urate transporter in humans JO - PLoS Med VL - 5 UR - https://doi.org/10.1371/journal.pmed.0050197 DO - 10.1371/journal.pmed.0050197 ID - Caulfield2008 ER -